Vimarsana
Biggest News Aggregation in the World

Page 13 - Ischemic Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ischemic Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ischemic Stroke Today - Breaking & Trending Today

University of Cincinnati to lead NIH StrokeNet for next five years - Vimarsana News

University of Cincinnati to lead NIH StrokeNet for next five years

The University of Cincinnati and UC Health have been renewed as the National Coordinating Center of the National Institutes of Health (NIH) StrokeNet, which is the primary infrastructure for multicenter trials of stroke funded by NIH and the pipeline for new potential treatments for adults and children with stroke and those at risk for stroke.

World Stroke Day 2023: Stroke Prevention For A Healthier Tomorrow - Vimarsana News

World Stroke Day 2023: Stroke Prevention For A Healthier Tomorrow

Excessive alcohol intake can cause hypertension, while smoking harms the lungs and elevates stroke risk. TheHealthSite.com

No Benefit of Colchicine After Stroke, TIA: CHANCE-3 - Vimarsana News

No Benefit of Colchicine After Stroke, TIA: CHANCE-3

The anti-inflammatory agent, started within 24 hours of acute ischemic stroke or TIA, did not reduce subsequent stroke or other vascular events at 90 days in the CHANCE-3 trial.

Attorneys lay out arguments in SVMC malpractice trial - Vimarsana News

Attorneys lay out arguments in SVMC malpractice trial

Attorneys in a malpractice suit against Southwestern Vermont Medical Center that went to trial Monday offered differing descriptions of what occurred March 16, 2014, when the plaintiff was seen in

Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2 - Vimarsana News

Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2

This result, along with its ease of use, adds to the growing evidence that tenecteplase should be a first-line thrombolytic agent, trial investigators say.